Displaying items by tag: department of surgery

Surgeon Mark Deierhoi has performed more than 2,200 kidney transplants in his career and trained hundreds of students who say his patience as a teacher has had a tremendous impact.
The trial will seek to find out whether less-invasive endovascular surgery is always a better choice than traditional open surgical repair for veterans with aortic abdominal aneurysms.
UAB nurse Calvin Kennedy climbed some 17,000 feet before torn knee ligaments, avascular necrosis and an intestinal parasite forced the two-time kidney transplant recipient to halt his ascent just 5.5 hours from the summit.
With her 2-year-old granddaughter’s life in peril, 62-year-old Carol Graydon came to UAB to be tested as a living kidney donor — and was a perfect match.
One UAB School of Nursing faculty member is impacting outcomes for ostomy patients with online postoperative visits.
UAB's Air Force Special Operations Surgical Team was honored following a recent overseas deployment when the team commander received a prestigious award.
A multidisciplinary team will provide patients with advanced technology to diagnose and manage facial nerve disorders.
UAB neurosurgery’s commitment to quality care is reflected in outcomes that beat national averages in key measurements.
Joey Gase, whose mom was an organ and tissue donor upon death, will promote organ donation along with Sparks Energy for the Sparks Energy 300 on May 6.
UAB trauma surgeons support Stop the Bleed, a campaign to provide knowledge and equipment to the public in response to mass casualty events for use before EMS crews can arrive.
were with youMore than 1 million married women ages 15-44 across the United States are infertile. Janet McLaren Bouknight, M.D., offers insight on the symptoms, diagnosis and treatment of infertile couples trying to conceive.
A new clinical trial seeks to determine whether a machine that pumps warm, oxygenated blood in cadaver kidneys can improve quality of the organ prior to transplant.
Failure of hormone deprivation therapy used to slow prostate cancer in patients leads to castration-resistant prostate cancer, a lethal form of advanced disease with limited treatment options. Endostatin, used in combination therapy, may help delay onset of castration-resistant disease.
Page 10 of 14